Candriam Equities L Oncology Impact C/ LU1864481541 /
| NAV2024-04-30 | Chg.-1.1600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 225.1200USD | -0.51% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | 6.11 | 2.59 | -3.71 | -2.64 | 8.63 | 0.22 | -0.35 | -3.24 | 5.02 | 7.89 | 4.95 | +30.34% |
| 2020 | -1.52 | -5.41 | -3.15 | 12.05 | 8.47 | 1.34 | 4.36 | 2.08 | 3.44 | -2.27 | 5.74 | 3.79 | +31.33% |
| 2021 | 0.48 | -4.26 | -0.16 | 2.26 | 0.10 | 3.44 | -1.04 | 5.49 | -3.84 | 3.30 | -6.44 | 3.90 | +2.49% |
| 2022 | -10.55 | -1.82 | 4.57 | -5.92 | -1.41 | -0.04 | 4.29 | -3.22 | -4.78 | 6.96 | 5.99 | -3.52 | -10.50% |
| 2023 | 2.07 | -3.95 | 1.30 | 2.76 | -2.64 | 0.00 | 0.81 | -2.09 | -5.31 | -6.44 | 9.13 | 5.65 | +0.17% |
| 2024 | 1.29 | 4.06 | 1.42 | -3.47 | - | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.12% | 11.88% | 11.83% | 14.75% | 17.31% |
| Sharpe ratio | 0.56 | 3.30 | -0.19 | -0.34 | 0.28 |
| Best month | +5.65% | +9.13% | +9.13% | +9.13% | +12.05% |
| Worst month | -3.47% | -6.44% | -6.44% | -10.55% | -10.55% |
| Maximum loss | -6.87% | -6.87% | -16.81% | -26.56% | -26.56% |
| Outperformance | - | - | - | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,286.1599 | +2.84% | +0.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,442.7600 | +2.97% | +0.63% | |
| Candriam Equities L Oncology Imp... | reinvestment | 198.3500 | -0.60% | -10.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,170.2200 | +2.01% | +9.81% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,534.5200 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 237.7400 | +4.28% | +8.68% | |
| Candriam Equities L Oncology Imp... | paying dividend | 225.1200 | +1.55% | -3.45% | |
| Candriam Equities L Oncology Imp... | paying dividend | 182.2200 | +2.42% | -0.99% | |
| Candriam Equities L Oncology Imp... | paying dividend | 19,992.0000 | -0.45% | -2.73% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.5400 | +1.89% | +9.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,015.7000 | +0.34% | -7.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 251.7900 | +5.16% | +11.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 197.9000 | -0.99% | -11.09% | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.2300 | +2.41% | -1.00% | |
| Candriam Equities L Oncology Imp... | reinvestment | 185.1400 | +0.23% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,789.7600 | +2.33% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,746.7000 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.8800 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 261.5600 | +1.56% | -3.47% |
Performance
| YTD | +3.19% | ||
|---|---|---|---|
| 6 Months | +19.55% | ||
| 1 Year | +1.55% | ||
| 3 Years | -3.45% | ||
| 5 Years | +51.34% | ||
| Since start | +62.29% | ||
| Year | |||
| 2023 | +0.17% | ||
| 2022 | -10.50% | ||
| 2021 | +2.49% | ||
| 2020 | +31.33% | ||
| 2019 | +30.34% | ||
Dividends
| 2024-04-29 | 4.55 USD |
| 2023-04-28 | 3.39 USD |
| 2022-04-28 | 4.28 USD |
| 2021-04-28 | 4.15 USD |
| 2020-04-24 | 1.50 USD |
